U.S. High Growth Potential Companies

Alnylam Pharmaceuticals

Market Cap: US$42.9b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

Lumentum Holdings

Market Cap: US$7.3b

Manufactures and sells optical and photonic products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa.

Alkami Technology

Market Cap: US$2.8b

Provides cloud-based digital banking solutions in the United States.

TG Therapeutics

Market Cap: US$5.4b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

Ascendis Pharma

Market Cap: US$10.1b

Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.

Zevra Therapeutics

Market Cap: US$614.1m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

Credo Technology Group Holding

Market Cap: US$17.4b

Provides various high-speed connectivity solutions for optical and electrical Ethernet, and PCIe applications in the United States, Taiwan, Mainland China, Hong Kong, and internationally.

Circle Internet Group

Market Cap: US$43.9b

Operates as a platform, network, and market infrastructure for stablecoin and blockchain applications.

Axsome Therapeutics

Market Cap: US$5.0b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

AVITA Medical

Market Cap: US$153.3m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

LandBridge

Market Cap: US$4.3b

Owns and manages land and resources to support and enhance oil and natural gas development in the United States.

OneMain Holdings

Market Cap: US$7.1b

A financial service holding company, engages in the consumer finance and insurance businesses in the United States.

Nu Holdings

Market Cap: US$61.4b

Provides digital banking platform in Brazil, Mexico, Colombia, the Cayman Islands, and the United States.

Caris Life Sciences

Market Cap: US$8.2b

An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.

FTC Solar

Market Cap: US$84.9m

Engages in the manufacture and service of solar tracker systems in the United States, Asia, Europe, the Middle East, North Africa, South Africa, and Australia.

Atour Lifestyle Holdings

Market Cap: US$4.9b

Through its subsidiaries, develops lifestyle brands around hotel offerings in the People’s Republic of China.

Astera Labs

Market Cap: US$20.2b

Designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure.

Invesco Mortgage Capital

Market Cap: US$510.6m

Operates as a real estate investment trust (REIT) that invests, finances, and manages mortgage-backed securities and other mortgage-related assets in the United States.

ARMOUR Residential REIT

Market Cap: US$1.8b

Invests in residential mortgage-backed securities (MBS) in the United States.

Palomar Holdings

Market Cap: US$3.5b

A specialty insurance company, provides property and casualty insurance to individuals and businesses in the United States.

Ardelyx

Market Cap: US$1.0b

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

Super Micro Computer

Market Cap: US$32.5b

Develops and sells high performance server and storage solutions based on modular and open architecture in the United States, Europe, Asia, and internationally.

Niu Technologies

Market Cap: US$300.2m

Designs, manufactures, and sells electric scooters in the People's Republic of China, Europe, and internationally.

Mereo BioPharma Group

Market Cap: US$279.8m

A biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally.

Evolus

Market Cap: US$614.5m

A performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.

Legend Biotech

Market Cap: US$8.0b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

DLocal

Market Cap: US$3.1b

Operates a payment processing platform worldwide.

AST SpaceMobile

Market Cap: US$18.7b

Designs and develops the constellation of BlueBird satellites in the United States.

Alvotech

Market Cap: US$3.0b

Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.

Prairie Operating

Market Cap: US$168.1m

An independent energy company, engages in the acquisition, development, and production of crude oil, natural gas, and natural gas liquids in the United States.

Palantir Technologies

Market Cap: US$374.8b

Palantir Technologies Inc. builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally.

Solaris Energy Infrastructure

Market Cap: US$2.2b

Provides mobile and scalable equipment-based solutions for use in distributed power generation and management of raw materials used in the completion of oil and natural gas wells in the United States.

Wallbox

Market Cap: US$95.7m

A technology company, designs, manufactures, and distributes charging solutions for residential, business, and public applications in Europe, the Middle East, Asia, North America, and the Asia Pacific.

ArcLight Clean Transition II

Market Cap: US$303.0m

As of July 21, 2022, ArcLight Clean Transition Corp.

DoorDash

Market Cap: US$105.9b

Operates a commerce platform that connects merchants, consumers, and independent contractors in the United States and internationally.

ARS Pharmaceuticals

Market Cap: US$1.8b

A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.